Feb 13 (Reuters) - MyMD Pharmaceuticals Inc MYMD.O :
* MYMD PHARMACEUTICALS ANNOUNCES REVERSE STOCK SPLIT TO
MAINTAIN
NASDAQ LISTING
* MYMD PHARMACEUTICALS INC - INTENDS TO EFFECT A REVERSE
STOCK
SPLIT OF ITS COMMON STOCK AT A RATIO OF 1 POST-SPLIT SHARE FOR
EVERY 30 PRE-SPLIT SHARES
* MYMD PHARMACEUTICALS INC - COMMON STOCK WILL BEGIN TRADING
ON
SPLIT-ADJUSTED BASIS ON FEBRUARY 15, 2024
* MYMD PHARMACEUTICALS INC: REVERSE STOCK SPLIT WILL BECOME
EFFECTIVE AT 4:05 P.M. EASTERN STANDARD TIME ON FEB 14, 2024
Source text for Eikon: ID:nBw3Ml1VGa
Further company coverage: MYMD.O
((Reuters.Briefs@thomsonreuters.com;))